Legend Biotech Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Legend Biotech stock have an average target of 79, with a low estimate of 60 and a high estimate of 90. The average target predicts an increase of 141.07% from the current stock price of 32.77.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$60	$79	$80	$90
Change	+83.09%	+141.07%	+144.13%	+174.64%

Analyst Ratings

The average analyst rating for Legend Biotech stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	6	6	6	6	6	5
Buy	7	7	7	7	6	6
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	13	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $75	Strong Buy	Reiterates	$75	+128.87%	Apr 16, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $75	Strong Buy	Reiterates	$75	+128.87%	Apr 8, 2025
Matthew Harrison Morgan Stanley	Morgan Stanley	Buy Maintains $82 → $80	Buy	Maintains	$82 → $80	+144.13%	Mar 17, 2025
Michael Schmidt Guggenheim	Guggenheim	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 12, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $73 → $75	Strong Buy	Maintains	$73 → $75	+128.87%	Mar 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.05B

from 627.24M

66.92%

from 627.24M

Revenue Next Year

1.59B

from 1.05B

51.77%

from 1.05B

EPS This Year

-0.83

from -0.97

EPS Next Year

0.37

from -0.83

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	75.00M	68.83M	117.01M	285.14M	627.24M	1.05B	1.59B	2.14B
Revenue Growth	21.36%	-8.23%	70.00%	143.70%	119.97%	66.92%	51.77%	34.80%
EPS	-2.26	-2.87	-2.81	-2.94	-0.97	-0.83	0.37	0.99
EPS Growth	-	-	-	-	-	-	-	170.89%
Forward PE	-	-	-	-	-	-	89.49	33.04
No. Analysts	-	-	-	-	-	23	20	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.2B	2.0B	2.9B
Avg	1.0B	1.6B	2.1B
Low	901.6M	1.2B	1.7B

Revenue Growth

Revenue Growth	2025	2026	2027
High	94.3%	88.5%	82.0%
Avg	66.9%	51.8%	34.8%
Low	43.7%	14.5%	9.8%

EPS Forecast

EPS	2025	2026	2027
High	-0.29	0.83	1.07
Avg	-0.83	0.37	0.99
Low	-1.32	-	0.91

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	191.0%
Avg	-	-	170.9%
Low	-	-	148.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.